Recombinant NDV-vectored vaccine expressing mosaic HA and M2e confers broad and early protection against H9N2 avian influenza virus
Frontiers in Immunology · 06.11.2026 · 17
DOI: 10.3389/fimmu.2026.1985015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 06.11.2026. Verfasst von Liren Jiang und 13 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The development of a universal H9N2 avian influenza vaccine is essential to reduce the occurrence of disease and economic losses in the poultry industry. In this study, we developed a recombinant vaccine rTS-mH9-3M2e based on Newcastle disease virus (NDV) avirulent strain TS09-C, containing a chimeric mosaic H9 HA and three copies of H9N2 avian influenza virus (AIV) M2e. The 1-day-old chickens were vaccinated with rTS-mH9-3M2e, which induced broad neutralizing antibody activity against H9N2 AIV, effectively reduced viral load and virus shedding, and reduced clinical signs and tissue damage. Furthermore, rTS-mH9-3M2e can induce cross-neutralizing response to the heterologous subtype AIV H3N2 and conferred cross-protection against H3N2 AIV. When rTS-mH9-3M2e was used as in ovo vaccine, it conferred the earlier protection against NDV and H9N2 AIV compared with post-hatch vaccination. rTS-mH9-3M2e in ovo vaccination significantly increased the level of splenic CD8 + T cells in chickens at 7 days of age and provided 100% protection against H9N2 AIV and 80% protection for NDV virulent strain. These results support that rTS-mH9-3M2e is a promising candidate for development as a broad H9N2 avian influenza vaccine and an in ovo vaccine.
Zitieren
APA
Jiang, L., Wen, G., Suo, X., Zeng, Z., Wu, Z., Zhu, Y., Shang, Y., Wang, H., Yao, L., Wang, R., Wang, S., Gao, M., Luo, Q., & Feng, H. (2026). Recombinant NDV-vectored vaccine expressing mosaic HA and M2e confers broad and early protection against H9N2 avian influenza virus. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1985015
Vancouver
Jiang L, Wen G, Suo X, Zeng Z, Wu Z, Zhu Y, et al. Recombinant NDV-vectored vaccine expressing mosaic HA and M2e confers broad and early protection against H9N2 avian influenza virus. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1985015
BibTeX
@article{Jiang2026,
author = {Jiang, Liren and Wen, Guoyuan and Suo, Xiaoyu and Zeng, Zhe and Wu, Zhouchu and Zhu, Yuqiao and Shang, Yu and Wang, Hongcai and Yao, Lun and Wang, Runjin and Wang, Shixin and Gao, Mingxin and Luo, Qingping and Feng, Helong},
title = {Recombinant NDV-vectored vaccine expressing mosaic HA and M2e confers broad and early protection against H9N2 avian influenza virus},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1985015}
}
EUVIMED